MariaCDall'EraMD

Rheumatology • San Francisco, CA

Associate Professor, Medicine, UCSF School of Medicine

Join to view full profile

Dr. Dall'Era is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dall'Era's full profile

Already have an account?

Office
400 Parnassus Ave
San Francisco, CA 94143
Phone+1 415-476-0783

Education & Training

University of California (San Francisco)Fellowship, Rheumatology, 2001 - 2004
University of California (San Francisco)Residency, Internal Medicine, 1997 - 2001
University of California San Francisco School of MedicineClass of 1997

Certifications & Licensure

CA State Medical License 1999 - 2025
American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Fellow American College of Rheumatology

Clinical Trials

Etanercept for the Treatment of Lupus Nephritis Start of enrollment: 2008 Feb 01
Terminated
Phase 2
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE) Start of enrollment: 2013 Nov 20
Terminated
Phase 2
Nelfinavir in Systemic Lupus Erythematosus Start of enrollment: 2014 Sep 01
Terminated
Phase 2
Rituximab and Belimumab for Lupus Nephritis Start of enrollment: 2015 Jul 09
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

61 citations
Prevalence of Systemic Lupus Erythematosus in the United States: Estimates From a Meta-Analysis of the Centers for Disease Control and Prevention National Lupus Regist...
Peter M. Izmirly, Hilary Parton, Lu Wang, W. Joseph McCune, S. Sam Lim
Arthritis & Rheumatology. 2021-06-01
217 citations
Type I interferon correlates with serological and clinical manifestations of SLE.
Maria Dall'Era, Pina M. Cardarelli, Benjamin T. Preston, Alison Witte, John C. Davis
Annals of the Rheumatic Diseases. 2005-12-01
57 citations
Identification of biomarkers that predict response to treatment of lupus nephritis with mycophenolate mofetil or pulse cyclophosphamide.
Maria Dall'Era, David H. Stone, Victoria Levesque, Miriam Cisternas, David Wofsy
Arthritis Care & Research. 2010-11-15

Press Mentions

New Research Findings in Lupus from ACR 2022January 16th, 2023